Table 2: Neonatal thyroid disfunction in the study group.

Patient no. Group Gestational age (week) Maternal TSH level (mIU/mL)*Maternal FT4 level (mIU/mL)*Treatment of the motherTSH level (mIU/mL) 1st week FT4 level (ng/dL)
1st week
TSH level (mIU/mL) 3rd week FT4 levels (ng/dL) 3rd week TSH level (mIU/mL) 8th week FT4 levels (ng/dL) 8th weekDiagnosisTreatment

1 I 38 5.61.1L-thyroxine 6.3 1.55 7.44 1.2 1.41.3Transient hyperthyrotropinemia (−)
2 I 36 5.71.7L-thyroxine10.7 1.2 14.4 1.06 4.21.5Transient compensated hypothyroidism (+)
3 II 40 7.21.7L-thyroxine30.7 1.9 12.4 2.2 3.21.7Transient hyperthyrotropinemia (−)
4 II 34 0.91.6L-thyroxine21.8 2.7 3.3 1.4 Transient hyperthyrotropinemia (−)
5 II 36 1.60.8L-thyroxine21.7 1.9 4.4 1.6 Transient hyperthyrotropinemia (−)
6 II 38 5.31.2L-thyroxine29.7 2.2 9.9 1.6 5.81.2Transient hyperthyrotropinemia (−)
7 II 37 3.20.7L-thyroxine20.9 2.1 5.2 1.3 Transient hyperthyrotropinemia (−)

If TSH > 7 mIU/mL, at the third week, TSH level is rechecked every two weeks until it comes down to normal values.